News and Announcements
As plant-based milks boom could Veggemo be the newest disruption to dairy?
- Published October 09, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Sales of non-dairy milk alternatives have boomed in the last six months.
- Veggemo is a non-dairy milk alternative that has several health benefits compared to it’s competitors.
- Breakthrough for plant-based milks as the Office for National Statistics in Britain added non-dairy milk into its consumer-price index.
Good news for Veggemo as the Economist features article on the disruption of the dairy industry and why plant based milks are the new alternative.
Demand for dairy alternatives has soared over the past six months, as nut and plant based milks are exceeding dairy sales.
A survey carried out by Mintel, a global research company, found that half of a sample of Americans had bought non-dairy milk over the last 3 months.
Last year the Office for National Statistics in Britain added non-dairy milk into its consumer-price index.
Plant-based milks are quickly becoming the new dairy alternative, sales in Britain grew by 76% last year with oat milk being the most popular seller.
Veggemo is a non-dairy milk originating from pea protein, tapioca & potato.
The dairy alternative has several benefits compared to other dairy and non-dairy alternatives such as high protein, low sugar, low fat and high in vitamins.
To read the full article click here.
About Veggemo (TSXV: VGM.CN)
Veggemo is a non-dairy milk originating from pea protein, tapioca & potato. The product can be used in a range of different uses including baking, cooking, coffees and smoothies. Veggemo’s is produced to cater for a wide range of dietary requirements and are cholesterol free, lactose-free, gluten free, soy & nut free, non-GMO, vegan, kosher.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
